Evidence map›Paper›PMID 25601659›Full record

ArticleNature communications2015

Comprehensive bioimaging with fluorinated nanoparticles using breathable liquids.

Michael E Kurczy, Zheng-Jiang Zhu, Julijana Ivanisevic, Adam M Schuyler, Kush Lalwani, Antonio F Santidrian, John M David, Anand Giddabasappa, Amanda J Roberts, Hernando J Olivos and 13 more

Abstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Molecular imaging of bacterial biofilms-a systematic review.Critical reviews in microbiology · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Role of Metabolomics in Brain Metabolism Research.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Michael E KurczyScripps Center for Metabolomics and Mass Spectrometry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Zheng-Jiang ZhuScripps Center for Metabolomics and Mass Spectrometry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Julijana IvanisevicScripps Center for Metabolomics and Mass Spectrometry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Adam M SchuylerScripps Center for Metabolomics and Mass Spectrometry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Kush LalwaniPfizer Worldwide Research and Development, 10724 Science Center Dr, San Diego, CA 92121, USA.
Antonio F SantidrianDepartments of Chemical Physiology and Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
John M DavidPfizer Worldwide Research and Development, 10724 Science Center Dr, San Diego, CA 92121, USA.
Anand GiddabasappaPfizer Worldwide Research and Development, 10724 Science Center Dr, San Diego, CA 92121, USA.
Amanda J RobertsDepartment of Molecular and Cellular Neuroscience, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Hernando J OlivosWaters Corporation, 100 Cummings Center, Beverly, Massachusetts 01915, USA.
Peter J O'BrienPfizer Worldwide Research and Development, 10724 Science Center Dr, San Diego, CA 92121, USA.
Lauren FrancoDepartment of Microbiology and Immunology and Center for Biofilm Engineering, Montana State University, 109 Lewis Hall, Montana State University, Bozeman, Montana 59717, USA.
Matthew W FieldsDepartment of Microbiology and Immunology and Center for Biofilm Engineering, Montana State University, 109 Lewis Hall, Montana State University, Bozeman, Montana 59717, USA.
Liliana P ParisDepartment of Cell and Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Martin FriedlanderDepartment of Cell and Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Caroline H JohnsonScripps Center for Metabolomics and Mass Spectrometry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Adrian A EpsteinThe Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska 68198-5880, USA.
Howard E GendelmanThe Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska 68198-5880, USA.
Malcolm R WoodThe Core Microscopy Facility, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Brunhilde H FeldingDepartments of Chemical Physiology and Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Gary J Patti1] Department of Chemistry, Washington University in St. Louis, One Brookings Drive, St. Louis, Missouri 63130, USA [2] Departments Genetics and Medicine, Washington University School of Medicine, 660 South Euclid Ave., St Louis, Missouri 63110, USA.
Mary E SpilkerPfizer Worldwide Research and Development, 10724 Science Center Dr, San Diego, CA 92121, USA.
Gary Siuzdak1] Scripps Center for Metabolomics and Mass Spectrometry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA [2] Departments of Chemistry, Molecular and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

Funding

Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
Adult Stem Cells for Therapy of Visual DisordersR24EY017540 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI FRIEDLANDER, MARTIN · 2007 to 2011
$17.5M
Pharmacokinetics and Drug-Drug InteractionsP01DA028555 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ALNOUTI, YAZEN · 2010 to 2019
$16.8M
INTEGRINS AND OCULAR ANGIOGENESISR01EY011254 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI FRIEDLANDER, MARTIN · 1996 to 2016
$11.5M
MicroRNAs for therapy of visual disordersR24EY022025 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI FRIEDLANDER, MARTIN · 2012 to 2016
$10.2M
Nanomedicine and NeuroAIDSR01NS036126 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 1997 to 2017
$5.7M
SMART HANDR01AG043540 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E, POLUEKTOVA, LARISA Y · 2013 to 2017
$3.1M
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS SynergyP01DA026146 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2008 to 2010
$2.9M
Normalizing Breast Cancer Metabolism to Prevent Progression and Recurrence (PQ21)R01CA170737 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI FELDING, BRUNIE H. · 2012 to 2015
$2.1M
Vascular mechanisms regulating breast cancer brain metastasisR01CA170140 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELICEIRI, BRIAN P, FELDING, BRUNIE H. · 2012 to 2016
$1.8M
Griffin: Venous Thromboembolism and mass spectrometry-based untargeted metabolomiRC1HL101034 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI DEGUCHI, HIROSHI, GRIFFIN, JOHN H · 2009 to 2010
$952k
NCI NIH HHS R01 CA170140NCI NIH HHS R01 CA170737NEI NIH HHS R01 EY011254NEI NIH HHS R24 EY017540NEI NIH HHS R24 EY022025NHLBI NIH HHS RC1 HL101034NIA NIH HHS R01 AG043540NIDA NIH HHS P01 DA026146NIDA NIH HHS P01 DA028555NIMH NIH HHS P30 MH062261NINDS NIH HHS R01 NS036126
6 · The paper itself

Abstract

Fluorocarbons are lipophobic and non-polar molecules that exhibit remarkable biocompatibility, with applications in liquid ventilation and synthetic blood. The unique properties of these compounds have also enabled mass spectrometry imaging of tissues where the fluorocarbons act as a Teflon-like coating for nanostructured surfaces to assist in desorption/ionization. Here we report fluorinated gold nanoparticles (f-AuNPs) designed to facilitate nanostructure imaging mass spectrometry. Irradiation of f-AuNPs results in the release of the fluorocarbon ligands providing a driving force for analyte desorption. The f-AuNPs allow for the mass spectrometry analysis of both lipophilic and polar (central carbon) metabolites. An important property of AuNPs is that they also act as contrast agents for X-ray microtomography and electron microscopy, a feature we have exploited by infusing f-AuNPs into tissue via fluorocarbon liquids to facilitate multimodal (molecular and anatomical) imaging.

Indexed as

Diagnostic ImagingGoldMass SpectrometryMetal NanoparticlesMicroscopy, ElectronNanostructuresGold

Identifiers

PMID25601659
PMCPMC4454288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.